<unk>  can reduce the intestinal reabsorption of ciclosporin, possibly making it necessary to increase the dose. People with diabetes mellitus might need less insulin or oral antidiabetics when treated with<unk> , as it inhibits glucagon secretion more strongly and for a longer time span than insulin secretion. The bioavailability of bromocriptine is increased; besides being an antiparkinsonian, bromocriptine is also used for the treatment of acromegaly.
Octreotide
Edotreotide
Lanreotide
Fertirelin
Metoclopramide
Tenatoprazole
Leuprorelin
Rabeprazole